Affiliation:
1. Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
Abstract
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndromerelated
coronavirus-2 (SARS-CoV-2), has become an ongoing pandemic worldwide. However, there
are no vaccines or antiviral drugs with proven clinical efficacy. Therefore, a remedial measure is urgently
needed to combat the devastating COVID-19. The pharmacological activities of Nacetylcysteine
(NAC) and its potential functions in inhibiting the progression of COVID-19 make it a
promising therapeutic agent for the infection. In this mini-review, we discussed the therapeutic potential
of NAC in COVID-19 from the perspective of its multisite pharmacological actions.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Pharmacology,General Medicine
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献